Esther Kang (left) and Qi Yang The School of Human Ecology announces its first two hires as part of the Wisconsin Research, Innovation and Scholarly Excellence (RISE) Initiative. Esther Kang and Qi Yang, both incoming …
research
Celebrating Fall Research Competition recipients as 2024 application opens
The Fall Research Competition, offered by the Office of the Vice Chancellor for Research, is a chance for UW–Madison faculty members to receive vital funding support for research projects. Applications for the 2024 competition are …
Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies (JAMA Psychiatry; Raison)
Research on the benefits of psychedelic and MDMA-assisted treatments may result in new challenges. As this concept is explored, experts, including Professor Charles Raison (Human Ecology’s Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children and Families), weigh in key considerations.
Parental depression symptoms and internalizing mental health problems in autistic children
A new article by a School of Human Ecology research team, published in the Journal of Autism and Developmental Disorders, examines associations between parental depression symptoms and the internalizing problems of autistic youth. Lead author …
Keeler speaks to Channel 3000 about digital mapping project
Thomas et al: “When She Says Daddy”: Black Fathers’ Recidivism following Reentry from Jail
In this new article by Assistant Professor Alvin Thomas, and co-authored with Jennifer Wirth (MS 2020) and Professor Julie Poehlmann-Tynan, the team reports on the results of a study highlighting the resilience of Black fathers …
NYT interviews HDFS grad student Ortiz re: “God molecule” aka toad venom as novel treatments for depression & anxiety
Assoc Prof Litzelman co-authors new article on adult-child and spousal caregiver burden and potential contributors
Novel approaches to depression are more critical than ever: Q&A with Dr. Charles Raison
By Alison Rowe, Director of Strategic Communications Depression is the leading cause of disability around the world with more than 260 million people suffering from the condition that disproportionately affects females and people of two or …